JG
MYGN icon

Joel Greenblatt’s Myriad Genetics MYGN Stock Holding History

Joel Greenblatt’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,327
Closed -$174K – 1067
2020
Q3 		$174K Buy
+13,327
New +$169K 0.01% 953
2019
Q2 		– Sell
-20,055
Closed -$666K – 1234
2019
Q1 		$666K Buy
20,055
+5,145
+35% +$157K 0.01% 771
2018
Q4 		$433K Sell
14,910
-30,719
-67% -$1.11M 0.01% 793
2018
Q3 		$2.1M Buy
45,629
+21,878
+92% +$973K 0.03% 487
2018
Q2 		$888K Sell
23,751
-9,220
-28% -$311K 0.01% 606
2018
Q1 		$974K Sell
32,971
-111,800
-77% -$3.78M 0.01% 611
2017
Q4 		$4.97M Sell
144,771
-74,321
-34% -$2.51M 0.07% 354
2017
Q3 		$7.93M Sell
219,092
-39,720
-15% -$1.13M 0.12% 275
2017
Q2 		$6.69M Sell
258,812
-90,450
-26% -$1.92M 0.09% 308
2017
Q1 		$6.71M Buy
349,262
+60,220
+21% +$1.07M 0.09% 322
2016
Q4 		$4.82M Sell
289,042
-132,686
-31% -$2.4M 0.06% 385
2016
Q3 		$8.68M Buy
421,728
+60,898
+17% +$1.54M 0.11% 262
2016
Q2 		$11M Buy
360,830
+159,303
+79% +$5.53M 0.13% 252
2016
Q1 		$7.54M Buy
201,527
+5,163
+3% +$195K 0.08% 341
2015
Q4 		$8.47M Buy
+196,364
New +$8.3M 0.09% 321
2015
Q1 		– Sell
-568,865
Closed -$19.4M – 983
2014
Q4 		$19.4M Sell
568,865
-300,666
-35% -$10.7M 0.16% 218
2014
Q3 		$33.5M Sell
869,531
-247,820
-22% -$9.25M 0.33% 95
2014
Q2 		$43.5M Sell
1,117,351
-88,748
-7% -$3.3M 0.54% 25
2014
Q1 		$41.2M Sell
1,206,099
-110,215
-8% -$3.41M 0.62% 2
2013
Q4 		$27.6M Buy
1,316,314
+350,327
+36% +$8.86M 0.66% 3
2013
Q3 		$22.7M Buy
965,987
+413,312
+75% +$11.7M 0.74% 7
2013
Q2 		$14.8M Buy
+552,675
New +$16M 0.64% 19

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Joel Greenblatt's MYGN Position: Q4 2020 in Review

Joel Greenblatt sold out of Myriad Genetics (MYGN) in Q4 2020, closing a stake of 13,327 shares — an estimated $174K sold.

Joel Greenblatt first reported a position in MYGN in Q2 2013 and held it in 22 quarters. The position peaked at $43.5M in Q2 2014. 187 funds tracked by Wall St. Rank hold MYGN as of Q4 2020.

  • Joel Greenblatt reported no remaining Myriad Genetics position as of Q4 2020 after selling out during the quarter.
  • Joel Greenblatt sold 13,327 Myriad Genetics shares in Q4 2020, an estimated $174K.
  • Joel Greenblatt first reported a position in Myriad Genetics in Q2 2013 and held it in 22 quarters.
  • Joel Greenblatt's Myriad Genetics position peaked at $43.5M in Q2 2014.
  • 187 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2020.

Based on Gotham Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.